These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9765481)

  • 1. The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly.
    Borsetti A; Ohagen A; Göttlinger HG
    J Virol; 1998 Nov; 72(11):9313-7. PubMed ID: 9765481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
    Accola MA; Strack B; Göttlinger HG
    J Virol; 2000 Jun; 74(12):5395-402. PubMed ID: 10823843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis.
    Mammano F; Ohagen A; Höglund S; Göttlinger HG
    J Virol; 1994 Aug; 68(8):4927-36. PubMed ID: 8035491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release.
    Melamed D; Mark-Danieli M; Kenan-Eichler M; Kraus O; Castiel A; Laham N; Pupko T; Glaser F; Ben-Tal N; Bacharach E
    J Virol; 2004 Sep; 78(18):9675-88. PubMed ID: 15331700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly.
    Accola MA; Höglund S; Göttlinger HG
    J Virol; 1998 Mar; 72(3):2072-8. PubMed ID: 9499062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphopoietic determinants of HIV-1 Gag particles assembled in baculovirus-infected cells.
    Gay B; Tournier J; Chazal N; Carrière C; Boulanger P
    Virology; 1998 Aug; 247(2):160-9. PubMed ID: 9705909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation.
    Joshi A; Nagashima K; Freed EO
    J Virol; 2006 Aug; 80(16):7939-51. PubMed ID: 16873251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.
    Ono A; Demirov D; Freed EO
    J Virol; 2000 Jun; 74(11):5142-50. PubMed ID: 10799589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag).
    Sandefur S; Smith RM; Varthakavi V; Spearman P
    J Virol; 2000 Aug; 74(16):7238-49. PubMed ID: 10906178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.
    Ono A; Freed EO
    J Virol; 1999 May; 73(5):4136-44. PubMed ID: 10196310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.
    Kondo E; Mammano F; Cohen EA; Göttlinger HG
    J Virol; 1995 May; 69(5):2759-64. PubMed ID: 7707498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.
    Paillart JC; Göttlinger HG
    J Virol; 1999 Apr; 73(4):2604-12. PubMed ID: 10074105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway.
    Chazal N; Gay B; Carrière C; Tournier J; Boulanger P
    J Virol; 1995 Jan; 69(1):365-75. PubMed ID: 7983731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional domains of the capsid protein of human immunodeficiency virus type 1.
    Dorfman T; Bukovsky A; Ohagen A; Höglund S; Göttlinger HG
    J Virol; 1994 Dec; 68(12):8180-7. PubMed ID: 7966609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly.
    Spearman P; Wang JJ; Vander Heyden N; Ratner L
    J Virol; 1994 May; 68(5):3232-42. PubMed ID: 8151785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner.
    Demirov DG; Orenstein JM; Freed EO
    J Virol; 2002 Jan; 76(1):105-17. PubMed ID: 11739676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein.
    Tang C; Ndassa Y; Summers MF
    Nat Struct Biol; 2002 Jul; 9(7):537-43. PubMed ID: 12032547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release.
    Goff A; Ehrlich LS; Cohen SN; Carter CA
    J Virol; 2003 Sep; 77(17):9173-82. PubMed ID: 12915533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of Pr160(gag-pol) into virus particles requires the presence of both the major homology region and adjacent C-terminal capsid sequences within the Gag-Pol polyprotein.
    Huang M; Martin MA
    J Virol; 1997 Jun; 71(6):4472-8. PubMed ID: 9151838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160(gag-pol) into virus particles.
    Chiu HC; Yao SY; Wang CT
    J Virol; 2002 Apr; 76(7):3221-31. PubMed ID: 11884546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.